Susan Breslin

1.9k total citations · 1 hit paper
10 papers, 1.5k citations indexed

About

Susan Breslin is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Susan Breslin has authored 10 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Biomedical Engineering. Recurrent topics in Susan Breslin's work include HER2/EGFR in Cancer Research (4 papers), Cancer Cells and Metastasis (4 papers) and 3D Printing in Biomedical Research (3 papers). Susan Breslin is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Cancer Cells and Metastasis (4 papers) and 3D Printing in Biomedical Research (3 papers). Susan Breslin collaborates with scholars based in Ireland, United States and China. Susan Breslin's co-authors include Lorraine O’Driscoll, John Crown, Josephine Salimu, Aled Clayton, Vanesa G. Martínez, Sadhbh O’Neill, Michelle C. Lowry, Sweta Rani, Claire Corcoran and Martina Gogarty and has published in prestigious journals such as Blood, Cancer Research and British Journal of Cancer.

In The Last Decade

Susan Breslin

10 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Three-dimensional cell culture: the missing link in drug discovery

2012 980 citations Susan Breslin, Lorraine O’Driscoll Drug Discovery Today profile →

Peers

Susan Breslin

BE

ONCOL

MB

CR

CB

Miriam Zimmermann United Kingdom

Łukasz Łuczewski Poland

Weronika Przybyła Poland

José M. Ayuso United States

Matthew Ibbs Poland

Marta Kapałczyńska Poland

Claudia Dittfeld Germany

Esak Lee United States

Renata Bliźniak Poland

Caleb Jensen United States

Miriam Zimmermann United Kingdom

Susan Breslin

731 ×0.9

BE

715 ×1.3

ONCOL

461 ×0.9

MB

201 ×0.9

CR

247 ×1.4

CB

Citations per year, relative to Susan Breslin Susan Breslin (= 1×) peers Miriam Zimmermann

Countries citing papers authored by Susan Breslin

Since Specialization

Citations

This map shows the geographic impact of Susan Breslin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Breslin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Breslin more than expected).

Fields of papers citing papers by Susan Breslin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Breslin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Breslin. The network helps show where Susan Breslin may publish in the future.

Co-authorship network of co-authors of Susan Breslin

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Breslin. A scholar is included among the top collaborators of Susan Breslin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Breslin. Susan Breslin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Zhang, Lei, Huacheng Luo, Hong‐Min Ni, et al.. (2022). Ripk3 signaling regulates HSCs during stress and represses radiation-induced leukemia in mice. Stem Cell Reports. 17(6). 1428–1441. 11 indexed citations

2.

Zhang, Lei, Hui Xu, Li Fu, et al.. (2020). Myc-Miz-1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpα and Cebpδ. Blood. 135(14). 1133–1145. 18 indexed citations

3.

Conlon, Neil T., Michelle C. Lowry, Susan Breslin, et al.. (2018). Abstract 1834: Src inhibition overcomes neratinib resistance in HER2-positive breast cancer. Cancer Research. 78(13_Supplement). 1834–1834. 2 indexed citations

4.

Breslin, Susan, Michelle C. Lowry, & Lorraine O’Driscoll. (2017). Neratinib resistance and cross-resistance to other HER2-targeted drugs due to increased activity of metabolism enzyme cytochrome P4503A4. British Journal of Cancer. 116(5). 620–625. 45 indexed citations

5.

Martínez, Vanesa G., Sadhbh O’Neill, Josephine Salimu, et al.. (2017). Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles. OncoImmunology. 6(12). e1362530–e1362530. 111 indexed citations

6.

Breslin, Susan & Lorraine O’Driscoll. (2016). The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance. Oncotarget. 7(29). 45745–45756. 239 indexed citations

7.

Breslin, Susan & Lorraine O’Driscoll. (2014). Receptor Tyrosine Kinase Targeting in Multicellular Spheroids. Methods in molecular biology. 1233. 161–168. 1 indexed citations

8.

Corcoran, Claire, Sweta Rani, Susan Breslin, et al.. (2014). miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer. Molecular Cancer. 13(1). 71–71. 67 indexed citations

9.

Rani, Sweta, Claire Corcoran, Serena Germano, et al.. (2014). Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors. Cancer Research. 74(14). 3821–3833. 39 indexed citations

10.

Breslin, Susan & Lorraine O’Driscoll. (2012). Three-dimensional cell culture: the missing link in drug discovery. Drug Discovery Today. 18(5-6). 240–249. 980 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact